Search - tctmd.com

Displaying 701 - 720 of 989

Sort: Relevancy | Date

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

News Conference News AHA 2018

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Yael L. Maxwell

November 10, 2018

News Daily News

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

L.A. McKeown

October 26, 2018

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

News Daily News

Patients With Schizophrenia Reap Gains From CV Meds After MI

Todd Neale

October 24, 2018

News Daily News

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

L.A. McKeown

October 18, 2018

News Daily News

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Michael O'Riordan

October 12, 2018

News Opinion Off Script TCT 2018

Off Script: Phantom Hearts and the Elusive Nature of Angina

Kwan S. Lee

October 11, 2018

News Daily News

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Todd Neale

October 09, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Conference News TCT 2018

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Shelley Wood

September 26, 2018

News Daily News

Cath Lab Preactivated Less Than Half the Time in STEMI Cases: ACTION Registry

Michael O'Riordan

September 18, 2018

News Daily News

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Michael O'Riordan

September 12, 2018

Presentation ESC 2018

Association of dietary quality and risk of cardiovascular disease and mortality in 218,000 people from over 50 countries

Presenter: Andrew Mente

August 30, 2018

News Conference News ESC 2018

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Michael O'Riordan

August 28, 2018

News Conference News ESC 2018

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

Todd Neale

August 27, 2018

News Daily News

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

Lucy Hicks

August 24, 2018

Advertisement

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Patients With Schizophrenia Reap Gains From CV Meds After MI

More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Off Script: Phantom Hearts and the Elusive Nature of Angina

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

CorMicA Offers Glimmer of Hope for Testing, Treating Angina Without Obstructive CAD

Cath Lab Preactivated Less Than Half the Time in STEMI Cases: ACTION Registry

Early Discharge Safe in Patients Undergoing TAVR, Meta-analysis Shows

Association of dietary quality and risk of cardiovascular disease and mortality in 218,000 people from over 50 countries

Redefined ‘High-Quality’ Diet Lowers Risk of All-Cause Mortality: PURE

Tafamidis, a Transthyretin Stabilizer, Offers Hope for Rare Cardiomyopathy

Sobering News From Europe: CVD Risk Factors Are on the Rise or Holding Firm

AHA Scientific Statement Aims to Raise Awareness of Chagas Disease and Risk for Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content